Home
Our Story
Meet The Team
Pipeline
Press Releases
Contact
Publications
More
Sparian Biosciences
Sparian Biosciences is a clinical stage bio-pharmaceutical company focusing on discovering and developing new therapies to target the central nervous system (CNS).
Press Release
NEW YORK, NY, August 8th -- Sparian Biosciences Awarded $19 Million Five-Year NIH/NIDA Grant to Fund Development of SBS-518 for Stimulant Use Disorder Through Phase 1 Clinical Development ...